Filing Flows › Anika Therapeutics (ANIK) › Stock forecast & fair value
Anika Therapeutics (ANIK) stock forecast and price target
Anika Therapeutics (ANIK) trades at $14.55. The analysts' price target is $23.00 (+58%).
Anika Therapeutics' latest quarter
Anika Therapeutics, Q3 2026: revenue $30.6M (+10% year over year), operating margin -2.3%, net loss $311K, operating cash flow $8.4M. The chart follows the revenue to costs, profit and cash.
Questions
What is the price target for ANIK stock?
The analysts' 12-month target is $23.00, +58% from $14.55. The average rating is none.
Does Anika Therapeutics usually beat earnings estimates?
It beat the consensus EPS estimate in 100% of the quarters on record.
Is ANIK stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.